High prevalence and molecular analysis of Macrolide-nonsusceptible moraxella catarrhalis isolated from nasopharynx of healthy children in China

Microbial Drug Resistance

Volumn 18, Issue 4, 2012, Pages 417-426

  Liu, Yali ^a   Zhao, Chunjiang ^a,b   Zhang, Feifei ^b   Chen, Hongbin ^a   Chen, Minjun ^a   Wang, Hui ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; ERYTHROMYCIN; GENOMIC DNA; MACROLIDE; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CHINA; DNA SEQUENCE; ERMA GENE; ERMB GENE; GENE MUTATION; HUMAN; MEFA GENE; MEFE GENE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NASOPHARYNX; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-BACTERIAL AGENTS; ASYMPTOMATIC DISEASES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI INFECTIONS; HUMANS; INFANT; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MUTATION; NASOPHARYNX; PHYLOGENY; PREVALENCE; RNA, RIBOSOMAL, 23S;

MORAXELLA CATARRHALIS;

EID: 84864357204     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0175     Document Type: Article

References (43)

1. Amit, M., R. Berisio, D. Baram, J. Harms, A. Bashan, and A. Yonath. 2005. A crevice adjoining the ribosome tunnel: hints for cotranslational folding. FEBS Lett. 579:3207-3213.
2. Barry, A.L., and P.C. Fuchs. 1995. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrob. Agents. Chemother. 39:238-240.
3. Bjerrum, L., A. Boada, J.M. Cots, C. Llor, D. Forés Garcia, B. Gahrn-Hansen, and A. Munck. 2004. Respiratory tract infections in general practice: Considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur. J. Clin. Pharmacol. 60:23-28.
4. Blondeau, J.M., and G.S. Tillotson. 2000. Antimicrobial susceptibility patterns of respiratory pathogens-a global perspective. Semin. Respir. Infect. 15:195-207.
5. Brooks, L., A. Shaw, D. Sharp, and A.D. Hay. 2008. Towards a better understanding of patients' perspectives of antibiotic resistance and MRSA: A qualitative study. Fam. Pract. 25:341-348.
6. Bruinsma, N., J.M. Hutchinson, A.E. van den Bogaard, H. Giamarellou, J. Degener, and E.E. Stobberingh. 2003. Influence of population density on antibiotic resistance. J. Antimicrob. Chemother. 51:385-390.
7. Calatayud L., C. Ardanuy, E. Cercenado, A. Fenoll, E. Bouza, R. Pallares, R. Martín, and J. Liñ ares. 2007. Serotypes, clones, and mechanisms of resistance of erythromycin- resistant Streptococcus pneumoniae isolates collected in Spain. Antimicrob. Agents Chemother. 51:3240-3246.
8. Cars, O., S. Mosltad, and A. Melander. 2001. Variation in antibiotic use in the European Union. Lancet 357:1851-1853.
9. [CLSI] Clinical and Laboratory Standards Institute. Antimicrobial Susceptibility Testing of Fastidious or Infrequently Isolated Organisms; Approved Guideline. CLSI document M45-A. Wayne, PA, 2006.
10. Davie, J.J., J. Earl, S.P. de Vries, A. Ahmed, F.Z. Hu, H.J. Bootsma, K. Stol, P.W. Hermans, R.M. Wadowsky, G.D. Ehrlich, J.P. Hays, and A.A. Campagnari. 2011. Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates. BMC Genomics 12:70.
11. Davies, T.A., K. Bush, D. Sahm, and A. Evangelista. 2005. Predominance of 23S rRNA mutants among non-erm, nonmef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000. Antimicrob. Agents Chemother. 49:3031-3033.
12. Davies, T.A., L.M. Kelly, M.R. Jacobs, and P.C. Appelbaum. 2000. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies. J. Clin. Microbiol. 38:1444-1448.
13. de la Pedrosa, E.G., M.I. Morosini, M. van der Linden, P. Ruiz-Garbajosa, J.C. Galán, F. Baquero, R.R. Reinert, and R. Cantó n. 2008. Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B). Antimicrob. Agents Chemother. 52:1964-1969.
14. De Vries, S.P., H.J. Bootsma, J.P. Hays, and P.W. Hermans. 2009. Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol. Mol. Biol. Rev. 73:389-406.
15. de Vries, S.P., S.A. van Hijum, W. Schueler, K. Riesbeck, J.P. Hays, P.W. Hermans, and H.J. Bootsma. 2010. Genome analysis of Moraxella catarrhalis strain RH4, a human respiratory tract pathogen. J. Bacteriol. 192:3574-3583.
16. Doern, G.V., R.N. Jones, M.A. Pfaller, and K. Kugler. 1999. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 43:385-389.
17. Fass, R.J. 1993. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob. Agents Chemother. 37:2080-2086.
18. Guay, D.R. 1996. Macrolide antibiotics in paediatric infectious diseases. Drugs 51:515-536.
19. Harrison, C.J., C. Woods, G. Stout, B. Martin, and R. Selvarangan. 2009. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J. Antimicrob. Chemother. 63:511-519.
20. Hoogkamp-Korstanje, J.A., S.I. Dirks-Go, P. Kabel, W.L. Manson, E.E. Stobberingh, R.W. Vreede, and B.I. Davies. 1997. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. J. Antimicrob. Chemother. 39:411-414.
21. Khan, M.A., J.B. Northwood, F. Levy, S.J. Verhaegh, D.J. Farrell, A. Van Belkum, and J.P. Hays. 2010. bro {beta}- lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. J. Antimicrob. Chemother. 65:91-97.
22. Kumar, R., K. Indira, A. Rizvi, T. Rizvi, and L. Jeyaseelan. 2008. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India. J. Clin. Pharm. Ther. 33:625-634.
23. Lee, W.K., and B.W. Young. 2005. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 56:603-605.
24. Lindbaek, M., D. Berild, J. Straand, and P. Hjortdahl. 1999. Influence of prescription patterns in general practice on antimicrobial resistance in Norway. Br. J. Gen. Pract. 49:436-440.
25. Mazzariol, A., R. Koncan, L.A. Vitali, and G. Cornaglia. 2007. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycinsusceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. J. Antimicrob. Chemother. 59:1171-1176.
26. Mendes, C., M.E. Marin, F. Quinones, J. Sifuentes-Osornio, C.C. Siller, M. Castanheira, C.M. Zoccoli, H. Lopez, A. Sucari, F. Rossi, G.B. Angulo, A.J. Segura, C. Starling, I. Mimica, and D. Felmingham. 2003. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: Results from the PROTEKT surveillance study (1999-2000). Braz. J. Infect. Dis. 7:44-61.
27. Murphy, T.F., and G.I. Parameswaran. 2009. Moraxella catarrhalis, a human respiratory tract pathogen. Clin. Infect. Dis. 49:124-131.
28. Rantala, M., S. Huikko, P. Huovinen, and J. Jalava. 2005. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob. Agents. Chemother. 49:4180-4184.
29. Richard, M.P., A.G. Aguado, R. Mattina, and R. Marre. 1998. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: A European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. J. Antimicrob. Chemother. 41:207-214.
30. Rimbara, E., N. Noguchi, T. Kawai, and M. Sasatsu. 2008. Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob. Agents Chemother. 52:3465-3466.
31. Sattar, S.A., J. Tetro, and V.S. Springthorpe. 1999. Impact of changing societal trends on the spread of infections in American and Canadian homes. Am. J. Infect. Control 27 Suppl.:4-21.
32. Schlunzen, F., R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.
33. Vaneechoutte, M., G. Verschraegen, G. Claeys, B. Weise, and A.M. Van den Abeele. 1990. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J. Clin. Microbiol. 28:2674-2680.
34. Verhaegh, S.J., A. Streefland, J.K. Dewnarain, D.J. Farrell, A. van Belkum, and J.P. Hays. 2008. Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002. Microbiology 154:1178-1184.
35. Walsh, F., F. Carnegy, J. Willcock, and S. Amyes. 2004. Comparative in vitro activity of telithromycin against macrolide- resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. J. Antimicrob. Chemother. 53:793-796.
36. Wang, H., M. Chen, Y. Xu, H. Sun, Q. Yang, Y. Hu, B. Cao, Y. Chu, Y. Liu, R. Zhang, Y. Yu, Z. Sun, C. Zhuo, Y. Ni, B. Hu, T.Y. Tan, P.R. Hsueh, J.H. Wang, W.C. Ko, Y.H. Chen, and H. Wahjono. 2011. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: Report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Int. J. Antimicrob. Agents 38:376-383.
37. Wang, Y., X.Z. Shen, L. Yuan, Y.Y. Cai, M.H. Zhang, and Y.H. Yang. 2004. Resistance pattern of Moraxella Catarrhalis in children in Beijing. Chinese. J. Pract. Pediatr. 19:491-493.
38. Wekselman I., C. Davidovich, I. Agmon, E. Zimmerman, H. Rozenberg, A. Bashan, R. Berisio, and A. Yonath. 2009. Ribosome's mode of function: myths, facts and recent results. J. Pept. Sci. 15:122-130.
39. Wierzbowski, A.K., K. Nichol, N. Laing, T. Hisanaga, A. Nikulin, J.A. Karlowsky, D.J. Hoban, and G.G. Zhanel. 2007. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). J. Antimicrob. Chemother. 60:733-740.
40. Wise, R., T. Hart, O. Cars, M. Streulens, R. Helmuth, P. Huovinen, and M. Sprenger. 1998. Antimicrobial resistance. Is a major threat to public health. BMJ 317:609-610.
41. Wolff, B.J., W.L. Thacker, S.B. Schwartz, and J.M. Winchell. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549.
42. Yano, H., M. Suetake, A. Kuga, K. Irinoda, R. Okamoto, T. Kobayashi, and M. Inoue. 2000. Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center. J. Clin. Microbiol. 38:625-629.
43. Yoo, S.M., S.Y. Lee, K.H. Chang, S.Y. Yoo, N.C. Yoo, K.C. Keum, W.M. Yoo, J.M. Kim, and J.Y. Choi. 2009. Highthroughput identification of clinically important bacterial pathogens using DNA microarray. Mol. Cell. Probes 23:171-177.